Impax Laboratories, Inc.
IPXL
IPXL was delisted on the 4th of May, 2018.
158 hedge funds and large institutions have $1.14B invested in Impax Laboratories, Inc. in 2013 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 57 increasing their positions, 57 reducing their positions, and 15 closing their positions.
127% more call options, than puts
Call options by funds: $4.27M | Put options by funds: $1.88M
67% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 15
6% more funds holding
Funds holding: 149 → 158 (+9)
2% more capital invested
Capital invested by funds: $1.12B → $1.14B (+$20.5M)
0% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 57
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TGI
Tradewinds Global Investors
Los Angeles,
California
|
+$13.9M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$9.04M |
| 3 |
Neuberger Berman Group
New York
|
+$8.52M |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$8.37M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$6.25M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Apex Capital
Orinda,
California
|
-$23.1M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
-$19.2M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$11.8M |
| 4 |
BC
Broadfin Capital
New York
|
-$9.83M |
| 5 |
PC
PointState Capital
New York
|
-$4.99M |
IPXL Hedge Fund Activity: Q3 2013 in Review
158 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Impax Laboratories, Inc. (IPXL) for Q3 2013, worth a combined $1.14B — up 1.8% from $1.12B a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new IPXL positions and 15 closed out — a net gain of 10 holders — while 57 added to existing stakes and 57 trimmed.
The largest buyer was Tradewinds Global Investors, opening a new position worth an estimated $13.9M. The largest seller was Apex Capital, cutting an estimated $23.1M.
- 158 institutional investors held Impax Laboratories, Inc. (IPXL) as of Q3 2013, up from 149 in Q2 2013.
- Funds reported $1.14B of Impax Laboratories, Inc. stock for Q3 2013, up 1.8% quarter-over-quarter.
- 25 funds opened new Impax Laboratories, Inc. positions in Q3 2013 and 15 closed out, a net change of +10 holders.
- The largest Impax Laboratories, Inc. buyer in Q3 2013 was Tradewinds Global Investors, an estimated $13.9M added.
- The largest Impax Laboratories, Inc. seller in Q3 2013 was Apex Capital, an estimated $23.1M sold.
Based on aggregated 13F filings for Q3 2013.